Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase N3 (PKN3) is a serine/threonine protein kinase that belongs to the protein kinase C-related family. It functions as an effector molecule downstream of activated phosphoinositide 3-kinase (PI3K) and plays significant roles in cell signaling pathways related to cancer progression, angiogenesis, cytoskeletal remodeling, and bone resorption. Its expression is notable in prostate tumors and various cancer cell lines but is not detected at significant levels in most adult tissues under normal conditions.
As a kinase, the mechanism of action for drugs targeting PKN3 would be kinase inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Kinase N3 (PKN3).